Previous studies have implicated CBX4 in Wnt/β-catenin activation in lung adenocarcinoma (showing a positive correlation with β-catenin levels) [23] and laryngeal cancer (via the circ_PVT1/miR-21-5p/CBX4 axis) [53]. Here, CBX4 is linked to laryngeal carcinoma.